Emphasis on Source (Animal-Derived, Plant-Derived, Synthetic); Manufacturing Process (Good Manufacturing Practice (GMP), Non-GMP); End-User (RNA Vaccines, Monoclonal Antibodies, Others); and Region/Country
Global Cholesterol API Market is expected to grow at a significant rate of around 4.8% during the forecast period. Cholesterol is the most used sterol in the formulation of liposomes which can prevent liposome aggregation and improve the liposomal membrane’s stability. Cholesterol plays a crucial role in the stability of a liposomal membrane. Thus, the rising use of liposomal formulations in drug delivery systems is set to boost sales of cholesterol APIs across the globe. Moreover, Cholesterol API is found in the lipid shells used in the production of RNA vaccines, giving the vaccine exceptional stability by halting the activity of enzyme breakdown. They are often derived from plants and animals, although they can also be chemically manufactured in laboratories. For instance, in March 2022, Croda International Plc, announced the support of the UK government to the expansion of its manufacturing facility which is estimated to boost the development of high-purity lipid systems for next-generation nucleic acid drugs such as mRNA vaccines. Thus, the above-mentioned factors drive the cholesterol API market.
Merck KGaA, Cayman Chemical, CordenPharma International, Croda International Plc, NOF CORPORATION, Nippon Fine Chemical Co., Ltd., Akums, Tokyo Chemical Industry Co., Ltd., Evonik Industries AG, CARBOGEN AMCIS are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst source, animal-derived held a significant share in the market in 2020”
Based on source, the market is segmented into animal-derived, plant-derived, and synthetic. The animal-derived category held a significant market share in 2020. Plant-derived bioactive compounds, often called phytochemicals, are active substances extracted from different plants. Plant-derived cholesterol is becoming more and more in demand. For instance, in 2021, Evonik Industries AG, Phytochol® is a plant-derived cholesterol for mRNA delivery, gene therapy, and cell culture. Cholesterol is an important functional excipient for parenteral mRNA-based drug delivery systems.
“Amongst end user, the RNA vaccines held a significant CAGR during the forecast period”
On the basis of end user, the market is categorized into RNA vaccines, monoclonal antibodies, and others. Among these, RNA vaccines held a significant CAGR during the forecast period. This is mainly due to the cholesterol-lowering vaccine could help tackle heart disease. RNA-Cholesterol nanoparticles function as potent immune activators via TLR7 and TLR8. The innate immune system senses viral and bacterial ribonucleic acid (RNA) via pattern recognition receptors (PRR) leading to subsequent activation of the immune system.
“APAC held a significant share in the market”
In 2020, APAC held a significant share of the global cholesterol API market. This is mainly attributed to the presence of multiple domestic and foreign API producers in China as well as their ongoing investments in the globalization of supply chains are credited with the industry’s growth. The market will be driven by the presence of multiple generic API producers in India as well as the development of that nation’s pharmaceutical sector. In addition, a big number of foreign companies are expected to enter the Indian market as a result of the availability of labor and raw commodities that are reasonably inexpensive. The region’s bioprocess industry is also anticipated to drive up demand for cholesterol APIs.
Reasons to buy this report:
Customization Options:
The global cholesterol API market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Market Synopsis
4. Executive Summary
5. Impact Of Covid-19 On The Cholesterol Api Market
6. Cholesterol Api Market Revenue (usd Bn), 2020-2028f
7. Market Insights By Source
8. Market Insights By Manufacturing Process
9. Market Insights By End-user
10. Market Insights By Region
11. Cholesterol Api Market Dynamics
12. Cholesterol Api Market Opportunities
13. Cholesterol Api Market Trends
14. Demand And Supply-side Analysis
15. Value Chain Analysis
16. Competitive Scenario
17. Company Profiled
18. Disclaimer
Research Methodology for the Cholesterol API Market Analysis (2022-2028)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global cholesterol API market were the three major steps undertaken to create and analyze the adoption of cholesterol APIs in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global cholesterol API market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the cholesterol API market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the cholesterol API market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as the source, manufacturing process, and end user. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the cholesterol API market. Further, we conducted factor analysis using dependent and independent variables such as various source, manufacturing process, end user of cholesterol APIs. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the cholesterol API market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global cholesterol API market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global cholesterol API market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of sources, manufacturing process, and end user in the global cholesterol API market.
The main objective of the Global Cholesterol API Market Study
The current & future market trends of the global cholesterol API market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
